Skip to main content

Pharma Complaint Hub

Pharma Complaint Hub logo
Clear Operational and Decision Boundaries

Regulatory & Service Disclaimer

This page explains the limits of Pharma Complaint Hub’s website content and services, the responsibilities that remain with pharmaceutical companies and authorized personnel, and the information that must not be submitted through the general website inquiry channel.

Last updated: July 23, 2026 Applies to: pharmacomplainthub.com General website and service boundary

Do Not Report a Product Complaint or Adverse Event Through This Website

Pharma Complaint Hub is not a public complaint-reporting portal, emergency service, healthcare provider, pharmaceutical manufacturer, Marketing Authorisation Holder or regulatory authority. Do not submit patient information, medical details, adverse-event narratives, product complaint records, case identifiers, photographs, source documents, samples or investigation evidence through the general contact form. Use the responsible company’s official reporting channel, a healthcare professional or the relevant authority.

Purpose of This Page

Clear Boundaries Protect Quality, Safety and Regulatory Accountability

Pharma Complaint Hub presents information about pharmaceutical complaint-operation services and provides general educational content for business audiences.

Our role is limited to operational, documentation, workflow, data-management and back-office support that is separately agreed with a client. The client retains ownership of its procedures, systems, products, records, regulated responsibilities and all final decisions.

Signed agreements control: A proposal, statement of work, quality agreement, safety-data exchange agreement, data-processing agreement or other signed contract may define a specific engagement. Website descriptions do not create an engagement or expand responsibilities beyond the signed terms.
Website Information

General business and educational information—not professional advice or a regulated decision.

Operational Services

Performed only under approved scope, access, procedures, training, oversight and contractual controls.

Client Authority Retained

Final Quality, PV, Medical, Legal, Technical and Regulatory authority remains with authorized client personnel.

Service Positioning

What Pharma Complaint Hub May Support—and What It Does Not Replace

Actual services depend on a separately approved engagement, client systems, procedures, access, training and oversight.

Operational and Documentation Support

Services may include client-authorized support for:

  • Complaint intake, registration and source preservation
  • Completeness review and missing-information follow-up
  • Product, batch, market and evidence organization
  • Authorized Quality and PV routing and handoff tracking
  • Investigation-documentation and returned-product coordination
  • Reconciliation, backlog remediation, analytics and reporting support

Functions We Do Not Replace

Pharma Complaint Hub does not act as:

  • A pharmaceutical manufacturer, sponsor or Marketing Authorisation Holder
  • A public complaint or adverse-event reporting portal
  • A regulator, health authority or official regulatory representative
  • A healthcare provider, emergency service or medical assessor
  • A law firm or provider of legal advice
  • The client’s final Quality, PV, Medical, Technical or Regulatory authority

Client-Controlled Framework

Engagement-specific work should operate under:

  • Client-approved procedures, forms and work instructions
  • Defined roles, escalation routes and decision ownership
  • Authorized systems, access permissions and security controls
  • Approved training, quality checks and performance oversight
  • Signed contracts and applicable quality, safety and data agreements

No Unsupported Outcome or Compliance Guarantee

Website descriptions do not guarantee:

  • Regulatory acceptance, inspection outcome or legal compliance
  • Complaint confirmation, root-cause identification or CAPA success
  • A fixed accuracy, turnaround, savings or productivity result
  • That a client system, process or product is compliant or risk-free
  • Any result not expressly supported by signed terms and actual evidence
Reserved Decision Authority

Final Regulated and Professional Decisions Remain with Authorized Parties

Operational documentation may support review, but it does not create authority to make the decisions below.

Quality and Technical Decisions

Defect classification, investigation strategy, testing, confirmation, root cause and technical conclusions.

Authorized owner

The manufacturer, MAH, sponsor and authorized Quality, Manufacturing, Laboratory, Engineering and Technical personnel.

Product and Batch Decisions

Product risk, batch impact, batch disposition, market action, field correction, recall and destruction.

Authorized owner

The responsible company and its authorized Quality, Regulatory, Medical, Supply, Legal and executive governance functions.

Pharmacovigilance and Medical Decisions

Case validity, causality, seriousness, expectedness, listedness, coding, medical assessment and signal evaluation.

Authorized owner

Authorized Pharmacovigilance, Drug Safety, Medical and clinical or scientific personnel.

Regulatory Decisions

Reportability, submission pathway, submission timing, authority correspondence and regulatory commitments.

Authorized owner

The responsible organization and authorized Pharmacovigilance, Medical, Regulatory Affairs, Quality and Legal personnel.

Quality-System Decisions

Deviation approval, nonconformance disposition, CAPA need, CAPA approval, effectiveness and complaint closure.

Authorized owner

The client’s authorized Quality-system owners and other responsible approvers designated by approved procedure.

Detailed Disclaimer

Website Content and Service Limitations

These provisions should be read together with the Terms of Use, Privacy Policy, Data Protection information and any signed service agreement.

Website Inquiry Guidance

What May—and May Not—Be Submitted Through the Contact Form

The general inquiry form is intended for high-level B2B discussion, not complaint or safety-case intake.

Appropriate High-Level Business Information

An initial inquiry may include:

  • Organization name and business contact details
  • Service areas of interest
  • Approximate complaint volumes or backlog ranges
  • High-level products, markets, languages and systems
  • General workflow challenges and desired support model
  • Preferred time for a confidential business discussion

Do Not Submit Through the General Website

Do not include:

  • Patient-identifiable or health information
  • Adverse-event or reaction narratives
  • Product complaint records or case identifiers
  • Reporter names, contact details or medical information
  • Real product labels, batch records, photographs or samples
  • Confidential investigations, CAPA records or regulatory correspondence
Frequently Asked Questions

Regulatory and Service Disclaimer FAQs

General answers about the website’s purpose and the service model.

Is Pharma Complaint Hub a pharmaceutical manufacturer or MAH?

No. Pharma Complaint Hub provides specialized operational and documentation support. It does not act as the manufacturer, sponsor or Marketing Authorisation Holder.

Can I report an adverse event or product complaint through the website?

No. The general website contact form is for high-level business inquiries only. Use the responsible product company’s official reporting route, a healthcare professional or the relevant authority.

Does Pharma Complaint Hub make reportability or causality decisions?

No. Final case validity, medical assessment, causality, seriousness, expectedness, listedness, reportability and submission decisions remain with authorized client Pharmacovigilance, Medical and Regulatory personnel.

Does Pharma Complaint Hub approve CAPA, recall or batch disposition?

No. Operational support may organize records and track status, but final root cause, CAPA, recall, product action and batch-disposition decisions remain with the responsible organization and authorized personnel.

Are the guides and checklists legally binding procedures?

No. They are general educational resources and must be reviewed, adapted, approved and controlled by the responsible organization before use in an operational process.

Does using an outsourced service transfer regulatory responsibility?

Not automatically. The client retains its applicable legal and regulated responsibilities, decision authority and oversight duties unless a valid legal framework expressly provides otherwise.

Do website service descriptions guarantee compliance or performance?

No. Service scope, controls, performance measures and responsibilities must be defined in signed engagement documents and supported by actual evidence.

What should an initial business inquiry contain?

Provide only high-level business information such as services of interest, approximate volumes, markets, languages, systems and desired support model. Do not include complaint, patient, medical or confidential records.

High-Level Business Inquiry

Discuss a Potential Complaint-Operations Engagement

Contact Pharma Complaint Hub with a high-level description of your products, markets, systems, approximate volumes, workflow needs and desired support model. Do not attach or submit patient, complaint, safety-case or confidential records.

Contact Pharma Complaint Hub
Legal-review boundary: This page is a general website and service-boundary draft prepared for the current Pharma Complaint Hub structure. It should be reviewed against the legal identity and location of the website operator, actual services, target jurisdictions, contracts, insurance, privacy and security arrangements, and applicable law. It does not constitute legal advice or guarantee enforceability in every jurisdiction.